CTOR insider filings
CITIUS ONCOLOGY, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-13. Screen CTOR transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| HOLUBIAK MYRON Z — Secretary, Director | 1 | — | — | 2 |
| Bartushak Jaime — Chief Financial Officer | 1 | — | — | 1 |
| Czuczman Myron — Chief Medical Officer | 1 | — | — | 1 |
| Dutia Suren G — Director | 1 | — | — | 1 |
| Holuka Eugene Myron — Director | 1 | — | — | 1 |
| MCGRATH DENNIS M — Director | 1 | — | — | 1 |
| Mayersohn Joel David — Director | 1 | — | — | 1 |
| Mazur Leonard L — Chief Executive Officer, Director | 1 | — | — | 1 |
| Peri Jonathan — Director | 1 | — | — | 1 |
| Smith Robert Joseph — Director | 1 | — | — | 1 |
+1 more insider in the window, not shown — every filing appears in the table below.
Recent insider filings — CITIUS ONCOLOGY, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Smith Robert Joseph — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Dutia Suren G — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | MCGRATH DENNIS M — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Holuka Eugene Myron — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Mayersohn Joel David — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Peri Jonathan — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Webb Carol — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Czuczman Myron — Chief Medical Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4/A | Smith Robert Joseph — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Czuczman Myron — Chief Medical Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Holuka Eugene Myron — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Webb Carol — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Mayersohn Joel David — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Dutia Suren G — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | MCGRATH DENNIS M — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 850,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Smith Robert Joseph — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Czuczman Myron — Chief Medical Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Holuka Eugene Myron — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Webb Carol — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Mayersohn Joel David — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Dutia Suren G — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | MCGRATH DENNIS M — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 850,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Smith Robert Joseph — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Czuczman Myron — Chief Medical Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Holuka Eugene Myron — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Webb Carol — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Mayersohn Joel David — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Dutia Suren G — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | MCGRATH DENNIS M — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 850,000 @ $0 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-08-07 | 4 | Mayersohn Joel David — Director | Other (J): 21,228 @ $0 | EDGAR |
| 2024-12-16 | 4 | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Holuka Eugene Myron — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Webb Carol — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Mayersohn Joel David — Director | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Dutia Suren G — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | MCGRATH DENNIS M — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CITIUS ONCOLOGY, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
GET https://api.filingpulse.io/v1/insider-trades?ticker=CTOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs